Kedaara Capital
Kedaara Capital is an operations-focused private equity firm.
Business Model:
Revenue: $53.3M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Kedaara Capital Information
Geographic Data
Address: Plot 42, Hotel Street
City: Ebene
State: plaines wilhems
Zip:
Country: MU
Financial Info
Stage:
Raised Last:
$0
Raised Total:$2B
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Kedaara Capital Investment Managers Limited (“Kedaara”) is an operationally-focused private equity firm, formed in partnership with CD&a;R and further supported by a number of India’s most successful business leaders and family-backed conglomerates. The firm targets two distinct types of investment opportunities in India: Corporate divestitures of under managed and/or non-core business units locked within large Indian-family conglomerates and have limited or no strategic value to their existing parent company; and Emerging leaders competing in selected sectors reaching critical mass in India, such as consumer, financial and business services, pharmaceuticals/healthcare and agriculture/resources. Kedaara is advised by a Mumbai-based investment advisory and operating team led by senior private equity professionals who most recently served in leadership roles at Temasek Holdings and General Atlantic after working together at McKinsey &a; Company in India.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2022 | ASG Eye Hospital | Secondary Market | 0 |
| 12/2018 | Aavas Financiers | Post-IPO Debt | 0 |
| 4/2017 | Spandana Sphoorty Financial | Private Equity Round | 100M |
| 1/2023 | Avanse Financial Services | Private Equity Round | 98.3M |
| 3/2022 | Spandana Sphoorty Financial | Post-IPO Equity | 0 |
| 10/2021 | Veritas Finance | Secondary Market | 0 |
| 3/2020 | Veritas Finance | Series E | 0 |
| 6/2022 | Purplle | Series E | 0 |
| 12/2017 | Spandana Sphoorty Financial | Venture Round | 19.5M |
| 10/2021 | Veritas Finance | Series F | 0 |
| 10/2021 | Purplle | Series D | 0 |
| 8/2022 | Oasis Fertility | Private Equity Round | 50.1M |
| 9/2019 | Lenskart | Series F | 0 |
| 3/2017 | Vijaya Diagnostic Centre | Series A | 7.7M |
| 2/2020 | Ami Lifesciences | Private Equity Round | 40M |
| 12/2016 | Vijaya Diagnostic Centre | Venture Round | 63.4M |
| 7/2022 | ASG Eye Hospital | Secondary Market | 0 |
| 6/2022 | Purplle | Series E | 0 |
| 3/2022 | Spandana Sphoorty Financial | Post-IPO Equity | 0 |
| 10/2021 | Purplle | Series D | 0 |
| 10/2021 | Veritas Finance | Secondary Market | 0 |
| 10/2021 | Veritas Finance | Series F | 0 |
| 3/2020 | Veritas Finance | Series E | 0 |
| 2/2020 | Ami Lifesciences | Private Equity Round | 0 |
| 9/2019 | Lenskart | Series F | 0 |
| 12/2018 | Aavas Financiers | Post-IPO Debt | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
